Biocon Ltd185.83bn8.04bn436.58bn3.68k Data as of Feb 04 2025. Currency figures normalised to Syngene International Ltd's reporting currency: Indian Rupee INR Institutional shareholders Top holders Movers Created with Highstock 5.0.9 19.52%Per cent of shares held by top holders ...
Syngene International Limited is an integrated research, development and manufacturing organisation providing scientific services – from early discovery to commercial supply. We offer services across wide range of sectors including pharmaceutical, nutrition, animal health, consumer goods and speciality chemical...
Syngene listed on BSE(Bombay Stock Exchange) & NSE(National Stock Exchange) of India 2015 Clinigene International Limited amalgamated with Syngene 2014 Bristol Myers Squibb and Syngene extend collaboration for its dedicated R&D center until 2020 2014 Acceptance of manufacturing facility by the Depart...
Syngene International LimitedIndustry: BiotechnologyProductions : service > cmo,service > cro & analytical labs Location: biocon park plot no.2 & 3, bommasandra iv phase, bangalore 560099, india Web: www.syngeneintl.comSocial Media: XFacebookLinkedInYouTube ...
Senior Manager, Quality Assurance, Syngene International Limited Syngene selected Impact Systems to implement the solution, and the project went live in just eight months from initiation. “The flexibility of the solution has allowed us, quite straightforwardly, to easily fine-tune processes to suit...
2,557 Number of newjoinees 27% Share of femalepermanent employeesin the workforce 0.07 Safety record TotalRecordable CaseFrequency (TRCF) Governance 50% Share of women inboard of directors 0 Number of suppliers/operations at riskfor incidents of child laboror forced labor ...
Syngene International announces Leadership changes More Press Release 10th Feb, 2025 From Compliance to Innovation: India’s CRDMOs Lead the Charge in Global Pharma Evolution More News 28th Jan, 2025 Sustainability: driving change in pharma and biotech business practices ...